Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell membrane; Multi-pass membrane protein. Golgi apparatus membrane; Multi-pass membrane protein. Note=Predominantly plasma membrane, some in Golgi apparatus. Some localization in the perinuclear region where it colocalizes with a sialyltransferase. |
Domain |
PF14360 PAP2 superfamily C-terminal |
Function |
Sphingomyelin synthases synthesize the sphingolipid, sphingomyelin, through transfer of the phosphatidyl head group, phosphatidylcholine, on to the primary hydroxyl of ceramide. The reaction is bidirectional depending on the respective levels of the sphingolipid and ceramide. Plasma membrane SMS2 can also convert phosphatidylethanolamine (PE) to ceramide phosphatidylethanolamine (CPE). Major form in liver. Required for cell growth in certain cell types. Regulator of cell surface levels of ceramide, an important mediator of signal transduction and apoptosis. Regulation of sphingomyelin (SM) levels at the cell surface affects insulin sensitivity. |
Biological Process |
GO:0006643 membrane lipid metabolic process GO:0006644 phospholipid metabolic process GO:0006665 sphingolipid metabolic process GO:0006672 ceramide metabolic process GO:0006684 sphingomyelin metabolic process GO:0006686 sphingomyelin biosynthetic process GO:0008654 phospholipid biosynthetic process GO:0030148 sphingolipid biosynthetic process GO:0046467 membrane lipid biosynthetic process GO:0046513 ceramide biosynthetic process GO:0097164 ammonium ion metabolic process |
Molecular Function |
GO:0016780 phosphotransferase activity, for other substituted phosphate groups GO:0033188 sphingomyelin synthase activity GO:0047493 ceramide cholinephosphotransferase activity |
Cellular Component |
GO:0030173 integral component of Golgi membrane GO:0030176 integral component of endoplasmic reticulum membrane GO:0031227 intrinsic component of endoplasmic reticulum membrane GO:0031228 intrinsic component of Golgi membrane GO:0031300 intrinsic component of organelle membrane GO:0031301 integral component of organelle membrane |
KEGG |
hsa04071 Sphingolipid signaling pathway hsa00600 Sphingolipid metabolism hsa01100 Metabolic pathways |
Reactome |
R-HSA-1430728: Metabolism R-HSA-556833: Metabolism of lipids and lipoproteins R-HSA-1660661: Sphingolipid de novo biosynthesis R-HSA-428157: Sphingolipid metabolism |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between SGMS2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of SGMS2 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of SGMS2 in various data sets.
|
Points in the above scatter plot represent the mutation difference of SGMS2 in various data sets.
|
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of SGMS2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of SGMS2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by SGMS2. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of SGMS2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of SGMS2 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between SGMS2 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | SGMS2 |
Name | sphingomyelin synthase 2 |
Aliases | MGC26963; SMS2; SM synthase; Phosphatidylcholine:ceramide cholinephosphotransferase 2 |
Chromosomal Location | 4q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting SGMS2 collected from DrugBank database. |
There is no record. |